Literature DB >> 11290465

Enhancing our understanding of multiple sclerosis: tracking contrast-enhancing plaques with MR imaging.

K R Maravilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11290465      PMCID： PMC7976026     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  6 in total

1.  Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history.

Authors:  J O Harris; J A Frank; N Patronas; D E McFarlin; H F McFarland
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

2.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Authors:  D H Miller; P S Albert; F Barkhof; G Francis; J A Frank; S Hodgkinson; F D Lublin; D W Paty; S C Reingold; J Simon
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

Review 3.  From enhancing lesions to brain atrophy in relapsing MS.

Authors:  J H Simon
Journal:  J Neuroimmunol       Date:  1999-07-01       Impact factor: 3.478

4.  Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions.

Authors:  M E Smith; L A Stone; P S Albert; J A Frank; R Martin; M Armstrong; H Maloni; D E McFarlin; H F McFarland
Journal:  Ann Neurol       Date:  1993-05       Impact factor: 10.422

5.  Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis.

Authors:  H F McFarland; J A Frank; P S Albert; M E Smith; R Martin; J O Harris; N Patronas; H Maloni; D E McFarlin
Journal:  Ann Neurol       Date:  1992-12       Impact factor: 10.422

6.  Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

Authors:  L Kappos; D Moeri; E W Radue; A Schoetzau; K Schweikert; F Barkhof; D Miller; C R Guttmann; H L Weiner; C Gasperini; M Filippi
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.